We aim to publish the evidence supporting the efficacy and effectiveness of our probiotics
Probiotic Research News
The MiBioGen consortium initiative
Recently, the MiBioGen (microbiome genome) consortium initiative was announced with the aim to gain a better understanding of the gut microbiome role as a mediator between genetic predisposition and health or disease in humans. The
Probiotics and acidosis in healthy children
A review of five randomised controlled trials from 2005 to 2017 with 544 healthy infants (one day to 12 months of age) showed that D-lactic acid producing probiotic bacteria and fermented infant formulas did not
Gut metabolome and abdominal obesity
The associations of metabolic products derived from gut microbes with age, obesity, host genetics and gut microbiome composition were investigated in the faecal samples of 786 predominantly female twins from the TwinsUK cohort (a national
Gut microbiome development in neonates
Various factors influence the gut microbiome development in neonates during prenatal, perinatal and postnatal periods, including maternal diet and lifestyle, mode of birth, feeding, antibiotic use and length of gestation. The reciprocal relationship between gut
The Research Team
Meet and learn about the Lab4 Probiotics research science team.
Can I take ProVen Probiotics with antibiotics? The answer to this question is a resounding YES – ProVen Probiotics can be taken both alongside and following a course of antibiotics! Read more on our latest blog: https://t.co/GJZlOnJ4wa
Read More
Still looking to shift those extra festive period pounds? Wanting to feel less bloated and healthier in yourself? Our Shapeline has had fantastic reviews ⭐⭐⭐⭐⭐: https://t.co/gKh3W4PIE9
Read More
'I take various probiotics, but my current favourites are Pro-ven Shapeline (£29.95, ) ...I notice a difference to my regularity when I don't take them.' https://t.co/yP3d99N0uT
Read MoreOur Research Partners
Want to know more?
If you can’t find what you are looking for or want to know more, please get in touch. We welcome all questions, comments, discussion and ideas.
